Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Author: CiceroArrigo F G, CorsiniAlberto, FerriNicola, FogacciFederica, RuscicaMassimiliano, TothPeter P

Paper Details 
Original Abstract of the Article :
AIM: Our aim was to assess the efficacy and safety of mipomersen through a systematic review of the literature and a meta-analysis of the available clinical studies. METHODS: A systematic literature search in SCOPUS, PubMed Medline, ISI Web of Science and Google Scholar databases was conducted up t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s40265-019-01114-z

データ提供:米国国立医学図書館(NLM)

Mipomersen: A Double-Edged Sword in Lipid Management

High cholesterol is a major health concern, and finding effective ways to manage it is crucial. This research investigates the [efficacy and safety] of [mipomersen], a drug designed to [reduce lipid levels]. The authors conduct a [systematic review and meta-analysis] of clinical trials, evaluating the impact of mipomersen on various lipid parameters, including [LDL cholesterol, total cholesterol, and triglycerides]. They also examine the potential [adverse effects] associated with this medication.

Mipomersen: A Mixed Bag of Benefits and Risks

The meta-analysis reveals that mipomersen is [effective] in reducing [LDL cholesterol, total cholesterol, non-HDL cholesterol, lipoprotein(a), apolipoprotein B, triglycerides, and very-low-density lipoprotein cholesterol] without affecting HDL-C levels. However, the study also highlights a [higher risk of discontinuation of treatment, injection-site reactions, hepatic steatosis, hepatic enzyme elevation, and flu-like symptoms] in patients receiving mipomersen.

Navigating Lipid Management: Weighing Benefits and Risks

This research underscores the importance of [carefully considering the potential risks and benefits] of any medication used to manage lipid levels. The authors emphasize the need for [individualized treatment decisions] based on each patient's specific needs and risk factors. By understanding the potential downsides of mipomersen, patients can work with their healthcare providers to make informed choices about their lipid management strategy.

Dr.Camel's Conclusion

This research, like a desert oasis offering both respite and potential hazards, reveals the complex nature of mipomersen. While it offers potential benefits for lowering lipid levels, its side effects require careful consideration. Ultimately, the decision to use mipomersen should be made in consultation with a healthcare professional, taking into account the individual patient's needs and risk profile.

Date :
  1. Date Completed 2019-11-27
  2. Date Revised 2020-02-25
Further Info :

Pubmed ID

30989634

DOI: Digital Object Identifier

10.1007/s40265-019-01114-z

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.